\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\:\\ \\ \\ if\\ pericardial\\ effusion\\ is\\ small\\ \\(0\\.5\\-1\\.0\\ cm\\ on\\ ct\\/mri\\)\\,\\ follow\\ with\\ serial\\ echocardiograms\\.\\ if\\ greater\\ than\\ 1\\.0\\-2\\.0\\ cm\\ and\\/or\\ if\\ patient\\ is\\ symptomatic\\,\\ treatment\\ is\\ pericardiocentesis\\ or\\ pericardial\\ window\\.\ \(0\)\
\-\ a\\ very\\ large\\ pericardial\\ effusion\\ is\\ seen\\ which\\ does\\ not\\ enhance\\ with\\ contrast\\,\\ and\\ which\\ is\\ hypodense\\ when\\ compared\\ to\\ adjacent\\ heart\\.\\ \\ additionally\\,\\ there\\ is\\ a\\ left\\ pleural\\ effusion\\ with\\ area\\ of\\ compressive\\ atelectasis\\ in\\ left\\ lower\\ lobe\\.\ \(0\)\
\-\ pericardial\\ effusion\ \(56\)\
\-\ of\\ pericardial\\ effusion\\:\\ none\\.\ \(0\)\
\-\ of\\ \\ cardiac\\ tamponade\\:\\ constrictive\\ pericarditis\\,\\ restrictive\\ cardiomyopathy\\.\ \(0\)\
\-\ patient\\ is\\ a\\ 19\\ year\\-old\\ female\\,\\ 24\\ weeks\\ pregnant\\,\\ with\\ history\\ of\\ systemic\\ lupus\\ erythematosus\\.\\ pt\\ now\\ presents\\ with\\ pleuritic\\ chest\\ pain\\.\\ pt\\ denies\\ sob\\.\ \(0\)\
\-\ excess\\ pericardial\\ fluid\\ may\\ be\\ present\\ in\\ all\\ forms\\ of\\ pericardial\\ disease\\,\\ including\\ percarditis\\ secondary\\ to\\ sle\\ and\\ other\\ collagen\\ vascular\\ diseases\\.\ \(0\)\
\-\ pericardial\\ effusion\\ in\\ the\\ setting\\ of\\ pericarditis\\ may\\ be\\ found\\ incidentally\\,\\ as\\ was\\ in\\ this\\ patient\\,\\ upon\\ imaging\\ studies\\ in\\ patients\\ complaining\\ of\\ pleuritic\\ chest\\ pain\\.\ \(0\)\
\-\ if\\ the\\ collection\\ of\\ fluid\\ is\\ rapid\\,\\ a\\ small\\ amount\\,\\ \\(100\\-200\\ ml\\ of\\ pericardial\\ fluid\\)\\,\\ can\\ result\\ in\\ cardiac\\ tamponade\\.\\ conversely\\,\\ if\\ accumulation\\ of\\ fluid\\ is\\ more\\ insipid\\,\\ larger\\ amounts\\ \\(up\\ to\\ 1500\\ ml\\)\\ can\\ accumulate\\ within\\ the\\ pericardium\\ without\\ tamponade\\ physiology\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pericardial\\:\\ 0\\.1775283110262383\ \(0\)\
\-\ effusion\\:\\ 0\\.08361821253747814\ \(0\)\
\-\ tamponade\\:\\ 0\\.07863692990812388\ \(0\)\
\-\ pleuritic\\:\\ 0\\.051350258196654786\ \(0\)\
\-\ pericarditis\\:\\ 0\\.05085962803493849\ \(0\)\
\-\ ml\\:\\ 0\\.05085962803493849\ \(0\)\
\-\ if\\:\\ 0\\.049758442784992175\ \(0\)\
\-\ fluid\\:\\ 0\\.04169337518633224\ \(0\)\
\-\ 1\\.0\\-2\\.0\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ percarditis\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ 100\\-200\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ insipid\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ 0\\.5\\-1\\.0\\:\\ 0\\.03485996241805388\ \(0\)\
\-\ ct\\/mri\\:\\ 0\\.033119768821023125\ \(0\)\
\-\ echocardiograms\\:\\ 0\\.031885081814792306\ \(0\)\
\-\ pericardiocentesis\\:\\ 0\\.031885081814792306\ \(0\)\
\-\ conversely\\:\\ 0\\.030144888217761557\ \(0\)\
\-\ 1500\\:\\ 0\\.030144888217761557\ \(0\)\
\-\ physiology\\:\\ 0\\.030144888217761557\ \(0\)\
\-\ accumulate\\:\\ 0\\.029483297317215384\ \(0\)\
\-\ constrictive\\:\\ 0\\.028404694620730808\ \(0\)\
\-\ restrictive\\:\\ 0\\.027952503566405374\ \(0\)\
\-\ cardiac\\:\\ 0\\.027938513244214338\ \(0\)\
\-\ pt\\:\\ 0\\.027271791885259678\ \(0\)\
\-\ amounts\\:\\ 0\\.025675129098327393\ \(0\)\
\-\ cardiomyopathy\\:\\ 0\\.025429814017469243\ \(0\)\
\-\ erythematosus\\:\\ 0\\.024977622963143806\ \(0\)\
\-\ pericardium\\:\\ 0\\.024768223116923067\ \(0\)\
\-\ excess\\:\\ 0\\.02456856639746001\ \(0\)\
\-\ compressive\\:\\ 0\\.022700248495065824\ \(0\)\
\-\ sle\\:\\ 0\\.021896765481811974\ \(0\)\
\-\ is\\:\\ 0\\.02171938628953876\ \(0\)\
\-\ pregnant\\:\\ 0\\.02159368579419844\ \(0\)\
\-\ lupus\\:\\ 0\\.02159368579419844\ \(0\)\
\-\ sob\\:\\ 0\\.02140290569732791\ \(0\)\
\-\ forms\\:\\ 0\\.021310604387366695\ \(0\)\
\-\ window\\:\\ 0\\.021220246407976855\ \(0\)\
\-\ collagen\\:\\ 0\\.020876715473755667\ \(0\)\
\-\ cm\\:\\ 0\\.019673443071390437\ \(0\)\
\-\ hypodense\\:\\ 0\\.019540079600537264\ \(0\)\
\-\ accumulation\\:\\ 0\\.019540079600537264\ \(0\)\
\-\ setting\\:\\ 0\\.018522355165820743\ \(0\)\
\-\ rapid\\:\\ 0\\.018522355165820743\ \(0\)\
\-\ diseases\\:\\ 0\\.01847493097617875\ \(0\)\
\-\ serial\\:\\ 0\\.01829030700586248\ \(0\)\
\-\ complaining\\:\\ 0\\.017901834870494102\ \(0\)\
\-\ enhance\\:\\ 0\\.017739859213915358\ \(0\)\
\-\ larger\\:\\ 0\\.01766110754581151\ \(0\)\
\-\ atelectasis\\:\\ 0\\.017622267050017872\ \(0\)\
\-\ chest\\:\\ 0\\.01755132188890574\ \(0\)\
\-\ systemic\\:\\ 0\\.017545624915253896\ \(0\)\
\-\ \\,\\:\\ 0\\.017427686621284594\ \(0\)\
\-\ 19\\:\\ 0\\.016911249359507927\ \(0\)\
\-\ small\\:\\ 0\\.016897641926018187\ \(0\)\
\-\ can\\:\\ 0\\.01663710173793193\ \(0\)\
\-\ incidentally\\:\\ 0\\.01662607725904375\ \(0\)\
\-\ may\\:\\ 0\\.016088655527022523\ \(0\)\
\-\ additionally\\:\\ 0\\.015894981268712253\ \(0\)\
\-\ compared\\:\\ 0\\.01552369696438057\ \(0\)\
\-\ collection\\:\\ 0\\.01552369696438057\ \(0\)\
\-\ and\\/or\\:\\ 0\\.01550005037291718\ \(0\)\
\-\ denies\\:\\ 0\\.015476533352468144\ \(0\)\
\-\ amount\\:\\ 0\\.015315426402600911\ \(0\)\
\-\ upon\\:\\ 0\\.014989306630163476\ \(0\)\
\-\ treatment\\:\\ 0\\.014846497507303751\ \(0\)\
\-\ symptomatic\\:\\ 0\\.014570744311992326\ \(0\)\
\-\ \\:\\:\\ 0\\.01455289462648925\ \(0\)\
\-\ 24\\:\\ 0\\.01425947201985386\ \(0\)\
\-\ pleural\\:\\ 0\\.014241846346237323\ \(0\)\
\-\ result\\:\\ 0\\.014069459901064214\ \(0\)\
\-\ greater\\:\\ 0\\.01377560668528112\ \(0\)\
\-\ studies\\:\\ 0\\.013697428831670213\ \(0\)\
\-\ which\\:\\ 0\\.013692228216674238\ \(0\)\
\-\ year\\-old\\:\\ 0\\.013471092796988054\ \(0\)\
\-\ very\\:\\ 0\\.013312384628571369\ \(0\)\
\-\ including\\:\\ 0\\.013242140090098385\ \(0\)\
\-\ heart\\:\\ 0\\.012742831111196454\ \(0\)\
\-\ now\\:\\ 0\\.012536976779835396\ \(0\)\
\-\ does\\:\\ 0\\.01251339515186269\ \(0\)\
\-\ vascular\\:\\ 0\\.012024906729286251\ \(0\)\
\-\ follow\\:\\ 0\\.011653216617795854\ \(0\)\
\-\ adjacent\\:\\ 0\\.01159586370873076\ \(0\)\
\-\ area\\:\\ 0\\.01159586370873076\ \(0\)\
\-\ found\\:\\ 0\\.011558049847433959\ \(0\)\
\-\ be\\:\\ 0\\.01131121650938995\ \(0\)\
\-\ patient\\:\\ 0\\.01102908065557581\ \(0\)\
\-\ in\\:\\ 0\\.010851430819062358\ \(0\)\
\-\ when\\:\\ 0\\.010503567543416333\ \(0\)\
\-\ weeks\\:\\ 0\\.010408917411592911\ \(0\)\
\-\ all\\:\\ 0\\.010373062186400389\ \(0\)\
\-\ secondary\\:\\ 0\\.010253347495745954\ \(0\)\
\-\ lobe\\:\\ 0\\.00986834913271903\ \(0\)\
\-\ up\\:\\ 0\\.009862004940146881\ \(0\)\
\-\ than\\:\\ 0\\.00960965173784667\ \(0\)\
\-\ patients\\:\\ 0\\.009491736477965777\ \(0\)\
\-\ \\(\\:\\ 0\\.009300794758504642\ \(0\)\
\-\ \\)\\:\\ 0\\.00918718058514985\ \(0\)\
\-\ more\\:\\ 0\\.009172430512069384\ \(0\)\
\-\ none\\:\\ 0\\.009097508613339083\ \(0\)\
\-\ pain\\:\\ 0\\.008958010021723044\ \(0\)\
\-\ without\\:\\ 0\\.008635249641022146\ \(0\)\
\-\ imaging\\:\\ 0\\.008592591521268681\ \(0\)\
\-\ other\\:\\ 0\\.008453384329195058\ \(0\)\
\-\ present\\:\\ 0\\.008283299373097342\ \(0\)\
\-\ lower\\:\\ 0\\.00824833506164748\ \(0\)\
\-\ contrast\\:\\ 0\\.008209337711621911\ \(0\)\
\-\ left\\:\\ 0\\.008206912182600126\ \(0\)\
\-\ large\\:\\ 0\\.008019495415584032\ \(0\)\
\-\ female\\:\\ 0\\.007539743654282548\ \(0\)\
\-\ presents\\:\\ 0\\.007492035603038309\ \(0\)\
\-\ seen\\:\\ 0\\.007247328820033005\ \(0\)\
\-\ within\\:\\ 0\\.006996272138996058\ \(0\)\
\-\ a\\:\\ 0\\.006808580288731352\ \(0\)\
\-\ disease\\:\\ 0\\.005994581721955812\ \(0\)\
\-\ as\\:\\ 0\\.005547542943751621\ \(0\)\
\-\ to\\:\\ 0\\.005498731009995531\ \(0\)\
\-\ there\\:\\ 0\\.005458006680107248\ \(0\)\
\-\ not\\:\\ 0\\.005299650951682126\ \(0\)\
\-\ history\\:\\ 0\\.005065298445094779\ \(0\)\
\-\ of\\:\\ 0\\.005000163124377186\ \(0\)\
\-\ or\\:\\ 0\\.004298380896839946\ \(0\)\
\-\ was\\:\\ 0\\.00424153443010166\ \(0\)\
\-\ this\\:\\ 0\\.004125052417657224\ \(0\)\
\-\ on\\:\\ 0\\.0031068283792507643\ \(0\)\
\-\ with\\:\\ 0\\.0025108192293967755\ \(0\)\
\-\ \\.\\:\\ 0\\.0019806608122982902\ \(0\)\
\-\ the\\:\\ 0\\.001780033708630375\ \(0\)\
\-\ and\\:\\ 0\\.0015451416801048794\ \(0\)\
